The global Rho-kinase Inhibitor Drugs market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Netarsudil Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Rho-kinase Inhibitor Drugs include Kowa Pharmaceuticals, Senju Pharmaceutical, Novartis, AERIE PHARMACEUTICALS and Redx Pharma, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Rho-kinase inhibitors (rho-associated protein kinase inhibitor or ROCK inhibitor) are?a series of compounds that target rho kinase (ROCK) and inhibit the ROCK pathway
This report aims to provide a comprehensive presentation of the global market for Rho-kinase Inhibitor Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rho-kinase Inhibitor Drugs. This report contains market size and forecasts of Rho-kinase Inhibitor Drugs in global, including the following market information:
- Global Rho-kinase Inhibitor Drugs Market Revenue, 2019-2024, 2025-2030, ($ millions)
- Global top five companies in 2023 (%)
We surveyed the Rho-kinase Inhibitor Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rho-kinase Inhibitor Drugs Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Rho-kinase Inhibitor Drugs Market Segment Percentages, by Type, 2023 (%)
- Netarsudil
- Ripasudil Hydrochloride Hydrate
- Fasudil
- Others
Global Rho-kinase Inhibitor Drugs Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Rho-kinase Inhibitor Drugs Market Segment Percentages, by Application, 2023 (%)
- Cerebral Vasospasm
- Glaucoma
- Others
Global Rho-kinase Inhibitor Drugs Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Rho-kinase Inhibitor Drugs Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Rho-kinase Inhibitor Drugs revenues in global market, 2019-2024 (estimated), ($ millions)
- Key companies Rho-kinase Inhibitor Drugs revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Kowa Pharmaceuticals
- Senju Pharmaceutical
- Novartis
- AERIE PHARMACEUTICALS
- Redx Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Rho-kinase Inhibitor Drugs, market overview.
Chapter 2: Global Rho-kinase Inhibitor Drugs market size in revenue.
Chapter 3: Detailed analysis of Rho-kinase Inhibitor Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Rho-kinase Inhibitor Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Rho-kinase Inhibitor Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Rho-kinase Inhibitor Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Rho-kinase Inhibitor Drugs Overall Market Size
2.1 Global Rho-kinase Inhibitor Drugs Market Size: 2023 VS 2030
2.2 Global Rho-kinase Inhibitor Drugs Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Rho-kinase Inhibitor Drugs Players in Global Market
3.2 Top Global Rho-kinase Inhibitor Drugs Companies Ranked by Revenue
3.3 Global Rho-kinase Inhibitor Drugs Revenue by Companies
3.4 Top 3 and Top 5 Rho-kinase Inhibitor Drugs Companies in Global Market, by Revenue in 2023
3.5 Global Companies Rho-kinase Inhibitor Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Rho-kinase Inhibitor Drugs Players in Global Market
3.6.1 List of Global Tier 1 Rho-kinase Inhibitor Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Rho-kinase Inhibitor Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Rho-kinase Inhibitor Drugs Market Size Markets, 2023 & 2030
4.1.2 Netarsudil
4.1.3 Ripasudil Hydrochloride Hydrate
4.1.4 Fasudil
4.1.5 Others
4.2 By Type - Global Rho-kinase Inhibitor Drugs Revenue & Forecasts
4.2.1 By Type - Global Rho-kinase Inhibitor Drugs Revenue, 2019-2024
4.2.2 By Type - Global Rho-kinase Inhibitor Drugs Revenue, 2025-2030
4.2.3 By Type - Global Rho-kinase Inhibitor Drugs Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Rho-kinase Inhibitor Drugs Market Size, 2023 & 2030
5.1.2 Cerebral Vasospasm
5.1.3 Glaucoma
5.1.4 Others
5.2 By Application - Global Rho-kinase Inhibitor Drugs Revenue & Forecasts
5.2.1 By Application - Global Rho-kinase Inhibitor Drugs Revenue, 2019-2024
5.2.2 By Application - Global Rho-kinase Inhibitor Drugs Revenue, 2025-2030
5.2.3 By Application - Global Rho-kinase Inhibitor Drugs Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Rho-kinase Inhibitor Drugs Market Size, 2023 & 2030
6.2 By Region - Global Rho-kinase Inhibitor Drugs Revenue & Forecasts
6.2.1 By Region - Global Rho-kinase Inhibitor Drugs Revenue, 2019-2024
6.2.2 By Region - Global Rho-kinase Inhibitor Drugs Revenue, 2025-2030
6.2.3 By Region - Global Rho-kinase Inhibitor Drugs Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Rho-kinase Inhibitor Drugs Revenue, 2019-2030
6.3.2 US Rho-kinase Inhibitor Drugs Market Size, 2019-2030
6.3.3 Canada Rho-kinase Inhibitor Drugs Market Size, 2019-2030
6.3.4 Mexico Rho-kinase Inhibitor Drugs Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Rho-kinase Inhibitor Drugs Revenue, 2019-2030
6.4.2 Germany Rho-kinase Inhibitor Drugs Market Size, 2019-2030
6.4.3 France Rho-kinase Inhibitor Drugs Market Size, 2019-2030
6.4.4 U.K. Rho-kinase Inhibitor Drugs Market Size, 2019-2030
6.4.5 Italy Rho-kinase Inhibitor Drugs Market Size, 2019-2030
6.4.6 Russia Rho-kinase Inhibitor Drugs Market Size, 2019-2030
6.4.7 Nordic Countries Rho-kinase Inhibitor Drugs Market Size, 2019-2030
6.4.8 Benelux Rho-kinase Inhibitor Drugs Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Rho-kinase Inhibitor Drugs Revenue, 2019-2030
6.5.2 China Rho-kinase Inhibitor Drugs Market Size, 2019-2030
6.5.3 Japan Rho-kinase Inhibitor Drugs Market Size, 2019-2030
6.5.4 South Korea Rho-kinase Inhibitor Drugs Market Size, 2019-2030
6.5.5 Southeast Asia Rho-kinase Inhibitor Drugs Market Size, 2019-2030
6.5.6 India Rho-kinase Inhibitor Drugs Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Rho-kinase Inhibitor Drugs Revenue, 2019-2030
6.6.2 Brazil Rho-kinase Inhibitor Drugs Market Size, 2019-2030
6.6.3 Argentina Rho-kinase Inhibitor Drugs Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Rho-kinase Inhibitor Drugs Revenue, 2019-2030
6.7.2 Turkey Rho-kinase Inhibitor Drugs Market Size, 2019-2030
6.7.3 Israel Rho-kinase Inhibitor Drugs Market Size, 2019-2030
6.7.4 Saudi Arabia Rho-kinase Inhibitor Drugs Market Size, 2019-2030
6.7.5 UAE Rho-kinase Inhibitor Drugs Market Size, 2019-2030
7 Rho-kinase Inhibitor Drugs Companies Profiles
7.1 Kowa Pharmaceuticals
7.1.1 Kowa Pharmaceuticals Company Summary
7.1.2 Kowa Pharmaceuticals Business Overview
7.1.3 Kowa Pharmaceuticals Rho-kinase Inhibitor Drugs Major Product Offerings
7.1.4 Kowa Pharmaceuticals Rho-kinase Inhibitor Drugs Revenue in Global Market (2019-2024)
7.1.5 Kowa Pharmaceuticals Key News & Latest Developments
7.2 Senju Pharmaceutical
7.2.1 Senju Pharmaceutical Company Summary
7.2.2 Senju Pharmaceutical Business Overview
7.2.3 Senju Pharmaceutical Rho-kinase Inhibitor Drugs Major Product Offerings
7.2.4 Senju Pharmaceutical Rho-kinase Inhibitor Drugs Revenue in Global Market (2019-2024)
7.2.5 Senju Pharmaceutical Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Rho-kinase Inhibitor Drugs Major Product Offerings
7.3.4 Novartis Rho-kinase Inhibitor Drugs Revenue in Global Market (2019-2024)
7.3.5 Novartis Key News & Latest Developments
7.4 AERIE PHARMACEUTICALS
7.4.1 AERIE PHARMACEUTICALS Company Summary
7.4.2 AERIE PHARMACEUTICALS Business Overview
7.4.3 AERIE PHARMACEUTICALS Rho-kinase Inhibitor Drugs Major Product Offerings
7.4.4 AERIE PHARMACEUTICALS Rho-kinase Inhibitor Drugs Revenue in Global Market (2019-2024)
7.4.5 AERIE PHARMACEUTICALS Key News & Latest Developments
7.5 Redx Pharma
7.5.1 Redx Pharma Company Summary
7.5.2 Redx Pharma Business Overview
7.5.3 Redx Pharma Rho-kinase Inhibitor Drugs Major Product Offerings
7.5.4 Redx Pharma Rho-kinase Inhibitor Drugs Revenue in Global Market (2019-2024)
7.5.5 Redx Pharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Rho-kinase Inhibitor Drugs Market Opportunities & Trends in Global Market
Table 2. Rho-kinase Inhibitor Drugs Market Drivers in Global Market
Table 3. Rho-kinase Inhibitor Drugs Market Restraints in Global Market
Table 4. Key Players of Rho-kinase Inhibitor Drugs in Global Market
Table 5. Top Rho-kinase Inhibitor Drugs Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Rho-kinase Inhibitor Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Rho-kinase Inhibitor Drugs Revenue Share by Companies, 2019-2024
Table 8. Global Companies Rho-kinase Inhibitor Drugs Product Type
Table 9. List of Global Tier 1 Rho-kinase Inhibitor Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Rho-kinase Inhibitor Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Rho-kinase Inhibitor Drugs Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Rho-kinase Inhibitor Drugs Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Rho-kinase Inhibitor Drugs Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Rho-kinase Inhibitor Drugs Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Rho-kinase Inhibitor Drugs Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Rho-kinase Inhibitor Drugs Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Rho-kinase Inhibitor Drugs Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Rho-kinase Inhibitor Drugs Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Rho-kinase Inhibitor Drugs Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Rho-kinase Inhibitor Drugs Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Rho-kinase Inhibitor Drugs Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Rho-kinase Inhibitor Drugs Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Rho-kinase Inhibitor Drugs Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Rho-kinase Inhibitor Drugs Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Rho-kinase Inhibitor Drugs Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Rho-kinase Inhibitor Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Rho-kinase Inhibitor Drugs Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Rho-kinase Inhibitor Drugs Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Rho-kinase Inhibitor Drugs Revenue, (US$, Mn), 2025-2030
Table 30. Kowa Pharmaceuticals Company Summary
Table 31. Kowa Pharmaceuticals Rho-kinase Inhibitor Drugs Product Offerings
Table 32. Kowa Pharmaceuticals Rho-kinase Inhibitor Drugs Revenue (US$, Mn) & (2019-2024)
Table 33. Kowa Pharmaceuticals Key News & Latest Developments
Table 34. Senju Pharmaceutical Company Summary
Table 35. Senju Pharmaceutical Rho-kinase Inhibitor Drugs Product Offerings
Table 36. Senju Pharmaceutical Rho-kinase Inhibitor Drugs Revenue (US$, Mn) & (2019-2024)
Table 37. Senju Pharmaceutical Key News & Latest Developments
Table 38. Novartis Company Summary
Table 39. Novartis Rho-kinase Inhibitor Drugs Product Offerings
Table 40. Novartis Rho-kinase Inhibitor Drugs Revenue (US$, Mn) & (2019-2024)
Table 41. Novartis Key News & Latest Developments
Table 42. AERIE PHARMACEUTICALS Company Summary
Table 43. AERIE PHARMACEUTICALS Rho-kinase Inhibitor Drugs Product Offerings
Table 44. AERIE PHARMACEUTICALS Rho-kinase Inhibitor Drugs Revenue (US$, Mn) & (2019-2024)
Table 45. AERIE PHARMACEUTICALS Key News & Latest Developments
Table 46. Redx Pharma Company Summary
Table 47. Redx Pharma Rho-kinase Inhibitor Drugs Product Offerings
Table 48. Redx Pharma Rho-kinase Inhibitor Drugs Revenue (US$, Mn) & (2019-2024)
Table 49. Redx Pharma Key News & Latest Developments
List of Figures
Figure 1. Rho-kinase Inhibitor Drugs Segment by Type in 2023
Figure 2. Rho-kinase Inhibitor Drugs Segment by Application in 2023
Figure 3. Global Rho-kinase Inhibitor Drugs Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Rho-kinase Inhibitor Drugs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Rho-kinase Inhibitor Drugs Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Rho-kinase Inhibitor Drugs Revenue in 2023
Figure 8. By Type - Global Rho-kinase Inhibitor Drugs Revenue Market Share, 2019-2030
Figure 9. By Application - Global Rho-kinase Inhibitor Drugs Revenue Market Share, 2019-2030
Figure 10. By Type - Global Rho-kinase Inhibitor Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Rho-kinase Inhibitor Drugs Revenue Market Share, 2019-2030
Figure 12. By Application - Global Rho-kinase Inhibitor Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Rho-kinase Inhibitor Drugs Revenue Market Share, 2019-2030
Figure 14. By Region - Global Rho-kinase Inhibitor Drugs Revenue Market Share, 2019-2030
Figure 15. By Country - North America Rho-kinase Inhibitor Drugs Revenue Market Share, 2019-2030
Figure 16. US Rho-kinase Inhibitor Drugs Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Rho-kinase Inhibitor Drugs Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Rho-kinase Inhibitor Drugs Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Rho-kinase Inhibitor Drugs Revenue Market Share, 2019-2030
Figure 20. Germany Rho-kinase Inhibitor Drugs Revenue, (US$, Mn), 2019-2030
Figure 21. France Rho-kinase Inhibitor Drugs Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Rho-kinase Inhibitor Drugs Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Rho-kinase Inhibitor Drugs Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Rho-kinase Inhibitor Drugs Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Rho-kinase Inhibitor Drugs Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Rho-kinase Inhibitor Drugs Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Rho-kinase Inhibitor Drugs Revenue Market Share, 2019-2030
Figure 28. China Rho-kinase Inhibitor Drugs Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Rho-kinase Inhibitor Drugs Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Rho-kinase Inhibitor Drugs Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Rho-kinase Inhibitor Drugs Revenue, (US$, Mn), 2019-2030
Figure 32. India Rho-kinase Inhibitor Drugs Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Rho-kinase Inhibitor Drugs Revenue Market Share, 2019-2030
Figure 34. Brazil Rho-kinase Inhibitor Drugs Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Rho-kinase Inhibitor Drugs Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Rho-kinase Inhibitor Drugs Revenue Market Share, 2019-2030
Figure 37. Turkey Rho-kinase Inhibitor Drugs Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Rho-kinase Inhibitor Drugs Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Rho-kinase Inhibitor Drugs Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Rho-kinase Inhibitor Drugs Revenue, (US$, Mn), 2019-2030
Figure 41. Kowa Pharmaceuticals Rho-kinase Inhibitor Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Senju Pharmaceutical Rho-kinase Inhibitor Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Novartis Rho-kinase Inhibitor Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. AERIE PHARMACEUTICALS Rho-kinase Inhibitor Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Redx Pharma Rho-kinase Inhibitor Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
